Rottinghaus Scott T.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Rottinghaus Scott T.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ENTA | Chief Medical Officer | Sale | 798 | $14.23 | $11,356 | Dec 5, 2025 |
| ENTA | Chief Medical Officer | Tax Withholding | 2,217 | $6.99 | $15,497 | Aug 8, 2025 |
| ENTA | Chief Medical Officer | Tax Withholding | 2,861 | $5.59 | $15,993 | Feb 12, 2025 |
| ENTA | Chief Medical Officer | Sale | 866 | $8.06 | $6,980 | Dec 6, 2024 |
| ENTA | Chief Medical Officer | Option Exercise | 5,375 | $8.99 | $48,321 | Jul 11, 2024 |
| ENTA | Chief Medical Officer | Award / Grant | 2,576 | — | — | Feb 12, 2024 |
| ENTA | Sr. VP & CMO | Sale | 534 | $9.63 | $5,142 | Dec 5, 2023 |
| ENTA | Chief Medical Officer | Tax Withholding | 1,466 | $12.73 | $18,662 | Aug 8, 2023 |
| ENTA | Chief Medical Officer | Award / Grant | 7,000 | — | — | Nov 23, 2022 |
| ENTA | Chief Medical Officer | Award / Grant | 20,000 | — | — | Aug 8, 2022 |